AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 151 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.66 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $80,873,000 | -35.5% | 1,930,369 | 0.0% | 75.24% | -8.5% |
| Q4 2015 | $125,320,000 | -8.0% | 1,930,369 | 0.0% | 82.23% | -4.0% |
| Q3 2015 | $136,265,000 | -36.5% | 1,930,369 | 0.0% | 85.66% | -1.7% |
| Q2 2015 | $214,541,000 | +17.9% | 1,930,369 | 0.0% | 87.15% | -3.6% |
| Q1 2015 | $182,034,000 | -15.8% | 1,930,369 | 0.0% | 90.41% | +0.6% |
| Q4 2014 | $216,278,000 | +82.6% | 1,930,369 | 0.0% | 89.87% | +7.6% |
| Q3 2014 | $118,428,000 | +33.9% | 1,930,369 | 0.0% | 83.56% | +10.6% |
| Q2 2014 | $88,450,000 | -41.5% | 1,930,369 | -50.0% | 75.54% | +13.9% |
| Q1 2014 | $151,148,000 | +63.5% | 3,860,738 | 0.0% | 66.32% | +12.4% |
| Q4 2013 | $92,465,000 | – | 3,860,738 | – | 58.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |